FI56839B - PROCEDURE FOR THE FRAMEWORK OF ANTIBAKTERIELLA PENICILLINDERIVAT - Google Patents

PROCEDURE FOR THE FRAMEWORK OF ANTIBAKTERIELLA PENICILLINDERIVAT

Info

Publication number
FI56839B
FI56839B FI2897/72A FI289772A FI56839B FI 56839 B FI56839 B FI 56839B FI 2897/72 A FI2897/72 A FI 2897/72A FI 289772 A FI289772 A FI 289772A FI 56839 B FI56839 B FI 56839B
Authority
FI
Finland
Prior art keywords
penicillinderivat
antibakteriella
framework
procedure
antibakteriella penicillinderivat
Prior art date
Application number
FI2897/72A
Other languages
Finnish (fi)
Other versions
FI56839C (en
Inventor
Hans-Bodo Koenig
Wilfried Schroeck
Karl Georg Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of FI56839B publication Critical patent/FI56839B/en
Publication of FI56839C publication Critical patent/FI56839C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
FI2897/72A 1971-10-23 1972-10-19 PROCEDURE FOR THE FRAMEWORK OF ANTIBAKTERIELLA PENICILLINDERIVAT FI56839C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2152967A DE2152967C3 (en) 1971-10-23 1971-10-23 Acylureidopenicillins
DE2152967 1971-10-23

Publications (2)

Publication Number Publication Date
FI56839B true FI56839B (en) 1979-12-31
FI56839C FI56839C (en) 1980-04-10

Family

ID=5823251

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2897/72A FI56839C (en) 1971-10-23 1972-10-19 PROCEDURE FOR THE FRAMEWORK OF ANTIBAKTERIELLA PENICILLINDERIVAT

Country Status (31)

Country Link
JP (2) JPS55391B2 (en)
AR (1) AR195805A1 (en)
AT (1) AT320152B (en)
BE (1) BE790440A (en)
BG (2) BG21609A3 (en)
CA (1) CA1019323A (en)
CH (1) CH579089A5 (en)
CS (1) CS188883B2 (en)
CY (1) CY947A (en)
DD (1) DD106044B3 (en)
DE (1) DE2152967C3 (en)
DK (1) DK134992C (en)
EG (1) EG10826A (en)
ES (1) ES407851A1 (en)
FI (1) FI56839C (en)
FR (1) FR2157908B1 (en)
GB (1) GB1392849A (en)
HK (1) HK18578A (en)
HU (1) HU167986B (en)
IE (1) IE37123B1 (en)
IL (1) IL40628A (en)
KE (1) KE2824A (en)
LU (1) LU66332A1 (en)
NO (1) NO143909C (en)
PH (1) PH9893A (en)
PL (2) PL89056B1 (en)
RO (2) RO63066A (en)
SE (1) SE412236B (en)
SU (1) SU527139A3 (en)
YU (1) YU264072A (en)
ZA (1) ZA727473B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4009272A (en) * 1971-10-23 1977-02-22 Bayer Aktiengesellschaft Penicillins
US3983105A (en) * 1971-10-23 1976-09-28 Bayer Aktiengesellschaft Penicillins
US3972870A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
NL175419C (en) * 1971-10-23 1984-11-01 Bayer Ag METHOD FOR PREPARING OR MANUFACTURING ANTIBIOTIC ACTIVE PHARMACEUTICAL PREPARATIONS AND METHOD FOR PREPARING ANTIBIOTIC ACTIVE ALPHA-SUBSTITUTED 6- (ALFA- (3-ACYLUREIDO) -PETYL-ACIDYL-ACIDYL-ACIDYL)
US3974141A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US3974142A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US3978056A (en) * 1971-10-23 1976-08-31 Bayer Aktiengesellschaft Penicillins
US3972869A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
DE2258973A1 (en) * 1972-12-01 1974-06-06 Bayer Ag PENICILLIN, THE METHOD FOR MANUFACTURING IT AND THEIR USE AS A MEDICINAL PRODUCT
JPS587637B2 (en) * 1973-12-27 1983-02-10 住友化学工業株式会社 Shinkipenicillin no Seihou
DE2407715C2 (en) * 1974-02-18 1982-12-02 Bayer Ag, 5090 Leverkusen Cephalosporins, processes for their production, as well as pharmaceuticals
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
DE2525541C2 (en) * 1975-06-07 1984-01-12 Bayer Ag, 5090 Leverkusen β-lactam antibiotics, processes for their preparation and pharmaceuticals containing them
DE2810083A1 (en) 1978-03-08 1979-09-20 Bayer Ag BETA-LACTAM COMPOUNDS
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
EP1780213A1 (en) 2005-10-27 2007-05-02 3M Innovative Properties Company Silicon-urea-azolides, their preparation and use in the preparation of silicones with isocyanate terminal groups
TWI417095B (en) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
EP2203439B1 (en) 2007-09-14 2011-01-26 Ortho-McNeil-Janssen Pharmaceuticals, Inc. 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-ý1, 4'¨bipyridinyl-2'-ones
WO2009033702A1 (en) 2007-09-14 2009-03-19 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
KR20100080597A (en) 2007-09-14 2010-07-09 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 1,3-disubstituted-4-phenyl-1h-pyridin-2-ones
EP2220083B1 (en) 2007-11-14 2017-07-19 Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CA2735764C (en) 2008-09-02 2016-06-14 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
CN102186477B (en) 2008-10-16 2013-07-17 奥梅-杨森制药有限公司 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
BRPI0921333A2 (en) 2008-11-28 2015-12-29 Addex Pharmaceuticals Sa indole and benzoxazine derivatives as metabotropic glutamate receptor modulators
PL2430022T3 (en) 2009-05-12 2014-02-28 Janssen Pharmaceuticals Inc 1,2,4-Triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153912A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 1, 2, 4,-triazolo[4,3-a[pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
KR102102972B1 (en) * 2009-06-10 2020-04-22 테크필즈 바이오켐 코., 엘티디. High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds
AU2011328195B2 (en) 2010-11-08 2015-04-02 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
CN103298809B (en) 2010-11-08 2016-08-31 杨森制药公司 1,2,4-triazol [4,3-a] pyridine derivate and the purposes of the positive allosteric modulators as MGLUR2 acceptor thereof
PT2649069E (en) 2010-11-08 2015-11-20 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JO3368B1 (en) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3367B1 (en) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
ES2860298T3 (en) 2014-01-21 2021-10-04 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators of metabotropic glutamatergic receptor subtype 2 and their use
EA033889B1 (en) 2014-01-21 2019-12-05 Янссен Фармацевтика Нв Combination comprising sv2a ligand and positive allosteric modulator of metabotropic glutamatergic receptor subtype 2

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1770620A1 (en) * 1968-06-12 1971-11-11 Bayer Ag New penicillins

Also Published As

Publication number Publication date
DK134992B (en) 1977-02-21
PL93574B1 (en) 1977-06-30
IE37123L (en) 1973-04-23
AR195805A1 (en) 1973-11-09
ES407851A1 (en) 1975-10-01
CY947A (en) 1978-06-23
BG20813A3 (en) 1975-12-20
BG21609A3 (en) 1976-07-20
IE37123B1 (en) 1977-05-11
PH9893A (en) 1976-06-08
FI56839C (en) 1980-04-10
NO143909B (en) 1981-01-26
DE2152967A1 (en) 1973-05-03
DD106044A5 (en) 1974-05-20
ZA727473B (en) 1973-07-25
AU4806472A (en) 1974-04-26
JPS55391B2 (en) 1980-01-08
IL40628A0 (en) 1972-12-29
LU66332A1 (en) 1973-01-23
CA1019323A (en) 1977-10-18
AT320152B (en) 1975-01-27
DK134992C (en) 1977-07-18
JPS4849787A (en) 1973-07-13
HU167986B (en) 1976-02-28
YU264072A (en) 1982-06-18
CH579089A5 (en) 1976-08-31
RO60670A (en) 1976-10-15
FR2157908A1 (en) 1973-06-08
EG10826A (en) 1976-12-31
KE2824A (en) 1978-04-07
SE412236B (en) 1980-02-25
CS188883B2 (en) 1979-03-30
FR2157908B1 (en) 1976-03-19
BE790440A (en) 1973-04-24
RO63066A (en) 1978-06-15
DE2152967C3 (en) 1981-11-19
JPS4849910A (en) 1973-07-14
GB1392849A (en) 1975-04-30
NO143909C (en) 1981-05-06
SU527139A3 (en) 1976-08-30
HK18578A (en) 1978-04-14
DD106044B3 (en) 1990-07-18
JPS57843B2 (en) 1982-01-08
DE2152967B2 (en) 1981-02-19
IL40628A (en) 1976-08-31
PL89056B1 (en) 1976-10-30

Similar Documents

Publication Publication Date Title
FI56839B (en) PROCEDURE FOR THE FRAMEWORK OF ANTIBAKTERIELLA PENICILLINDERIVAT
SE392269B (en) PROCEDURE FOR THE PREPARATION OF CERTAIN INDANYLOXITETRAZOLES
SE7509456L (en) PROCEDURE FOR PREPARING NEW PLEUROMUTILINES
SE402772B (en) PROCEDURE FOR MAKING NEW ISOTIOCYANOBENSAZOLES
SE401186B (en) PROCEDURE FOR MANUFACTURE OF NEW PENICILLINES
SE400292B (en) PROCEDURE FOR THE PREPARATION OF BENZHYDRYL-3-CARBAMOYLOXIMETHYL-7-THIENYLACETAMIDO-7-METHOXIDE CEFALOSPORANATE
SE397680B (en) PROCEDURE FOR THE PREPARATION OF NEW HETEROCYCLIC ESTERS OF BENZOPYRANOPYRIDINES
SE386902B (en) PROCEDURE FOR THE PREPARATION OF NEW CEPHALOSPORINS
SE417200B (en) PROCEDURE FOR THE PREPARATION OF 2-NITRO-5-IMIDAZOLALDEHYD HYDRIATIVES
SE405478B (en) PROCEDURE FOR THE PREPARATION OF ALFA-SULFOACYLCEPHALOSPORINES
SE382980B (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF HEXAHYDROFENANTRIDINE
SE397090B (en) PROCEDURE FOR THE PREPARATION OF HYDROXIPYRIMIDINES
SE390538B (en) PROCEDURE FOR MAKING NEW ACYLAMINOCEFALOSPORANIC ACIDS
SE387936B (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED METHOXYAMINES
SE383631B (en) PROCEDURE FOR MAKING NEW 1-PHENOXY-2-HYDROXIDE-3-HYDROXIALKYLAMINOPROPANES
SE384210B (en) PROCEDURE FOR THE PREPARATION OF NEW NITROSOCARBAMIDE DERIVATIVES
SE380520B (en) PROCEDURE FOR THE PREPARATION OF 1-CINNAMYLIDENAMINO-3-BENZYLIDENAMINOGUANIDINE
SE386897B (en) PROCEDURE FOR THE PREPARATION OF N-ACYL- (PIPERAZINOETHYL) -PYRAZOLES
SE392902B (en) PROCEDURE FOR THE PREPARATION OF PHENYLIMIDAZOLIDINONES
SE407061B (en) PROCEDURE FOR THE PREPARATION OF BENZYLPYRIMIDINES
SE387948B (en) PROCEDURE FOR THE PREPARATION OF TIOFEN
SE381054B (en) PROCEDURE FOR MAKING NEW THIAZOLOKINOLINE DERIVATIVES
SE394112B (en) PROCEDURE FOR THE PREPARATION OF NEW ESTRARS OF BENZOPYRANES.
SE7514792L (en) PROCEDURE FOR THE PRODUCTION OF UROKINAS
SE394279B (en) PROCEDURE FOR THE PREPARATION OF KINOXALINE DI-N-OXIDES